BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa

Antimicrob Agents Chemother. 2010 Jan;54(1):533-5. doi: 10.1128/AAC.00859-09. Epub 2009 Nov 2.

Abstract

A Pseudomonas aeruginosa isolate recovered in Belgium produced a novel extended-spectrum ss-lactamase, BEL-2, differing from BEL-1 by a single Leu162Phe substitution. That modification significantly altered the kinetic properties of the enzyme, increasing its affinity for expanded-spectrum cephalosporins. The bla(BEL-2) gene was identified from a P. aeruginosa isolate clonally related to another bla(BEL-1)-positive isolate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Belgium
  • Cephalosporinase / genetics
  • Cephalosporinase / metabolism*
  • Cephalosporins / pharmacology*
  • Cross Infection / microbiology
  • Escherichia coli / genetics
  • Genes, Bacterial / genetics
  • Humans
  • Kinetics
  • Microbial Sensitivity Tests
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / enzymology*
  • Pseudomonas aeruginosa / genetics
  • beta-Lactamases / genetics*
  • beta-Lactamases / metabolism*

Substances

  • Cephalosporins
  • Cephalosporinase
  • beta-Lactamases
  • beta-lactamase BEL-2, Pseudomonas aeruginosa